StagingTesting mode — staging environment. No real money: balances, trades, and accounts are for testing only and may be reset at any time.DEMODemo mode: simulated data, for showcase only

FDA novel Alzheimer's approvals in 2026?

Price and outcomes

About This Market

Counts new disease-modifying Alzheimer's therapies approved beyond lecanemab and donanemab. Resolves to the bucket matching the FDA total for 2026. Source: FDA.

Activity and discussion

Holders

FDA novel Alzheimer's approvals in 2026?

Amount

Related Markets

View all

FDA approves Novo's CagriSema in 2026?

41¢

+5%

$655.2K

GLP-1 obesity market leader end of 2026?

50¢$593.7K

WHO declares an H5N1 pandemic in 2026?

43¢

+2%

$545.3K

Tech & Science·Health & Biotech

FDA novel Alzheimer's approvals in 2026?

Price and outcomes

FDA novel Alzheimer's approvals in 2026?

About This Market

Counts new disease-modifying Alzheimer's therapies approved beyond lecanemab and donanemab. Resolves to the bucket matching the FDA total for 2026. Source: FDA.